NCT04701372

Brief Summary

This is a naturalistic, observational study of individuals with obsessive-compulsive disorder who were treated with exposure and response prevention via video teletherapy, augmented with between-session support with text messaging and an online community forum.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,069

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2020

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 8, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 8, 2020

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 2, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 8, 2021

Completed
Last Updated

January 8, 2021

Status Verified

January 1, 2021

Enrollment Period

10 months

First QC Date

January 2, 2021

Last Update Submit

January 7, 2021

Conditions

Obsessive-Compulsive Disorder

Keywords

exposure and response preventiondigital behavioral healthremote treatmentvideo therapy

Outcome Measures

Primary Outcomes (1)

  • Dimensional Obsessive-Compulsive Scale

    self-rated psychometric instrument to measure symptom severity of multiple OCD subtypes

    change from pre-treatment to post-treatment (after 11 weeks)

Secondary Outcomes (3)

  • Diagnostic Interview for Anxiety, Mood, and OCD and Related Neuropsychiatric Disorders (DIAMOND) OCD severity scale

    pre-treatment, after 4 weeks, and post-treatment (after 11 weeks)

  • Depression Anxiety and Stress Scale (DASS-21)

    pre-treatment, after 4 weeks, and post-treatment (after 11 weeks)

  • Quality of Life Enjoyment and Satisfaction Questionnaire -- Short Form (QLES-Q)

    pre-treatment, after 4 weeks, and post-treatment (after 11 weeks)

Study Arms (1)

Obsessive-Compulsive Disorder

adults, adolescents, and children with obsessive-compulsive disorder

Behavioral: Exposure and response prevention therapy

Interventions

Exposure and response prevention therapyBEHAVIORAL

Exposures and response prevention therapy (a type of cognitive-behavioral therapy for obsessive-compulsive disorder), delivered in real-time by licensed therapists remotely via video. The treatment was augmented by between-session text messaging and online community support.

Obsessive-Compulsive Disorder

Eligibility Criteria

Age10 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This is a naturalistic sample of children, adolescents, and adults with obsessive-compulsive disorder (OCD) who sought treatment for OCD from NOCD, LLC, a digital behavioral health company.

You may qualify if:

  • obsessive-compulsive disorder

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nocd, Llc

Chicago, Illinois, 60601, United States

Location

MeSH Terms

Conditions

Obsessive-Compulsive Disorder

Condition Hierarchy (Ancestors)

Anxiety DisordersMental Disorders

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 2, 2021

First Posted

January 8, 2021

Study Start

January 1, 2020

Primary Completion

November 8, 2020

Study Completion

November 8, 2020

Last Updated

January 8, 2021

Record last verified: 2021-01

Locations

US(1)